安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Homepage - GRAIL
Our Mission GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages
- Galleri Test - GRAIL
GRAIL uses advanced machine learning algorithms and pattern recognition to “read” methylation patterns Using these two principles, the Galleri test has three scientific steps: Extract and sequence the DNA fragments from the blood to “read” the methylation patterns (assay)
- Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in . . .
The Primary Endpoint of Statistically Significant Combined Stage III-IV Reduction Was Not Met, However A Favorable Trend Was Observed Over Time GRAIL Announces U S Sales Force Expansion Based on Strong NHS-Galleri and PATHFINDER 2 Trial Results MENLO PARK, Calif and LONDON – Feb 19, 2026 — GRAIL, Inc (Nasdaq: GRAL), a healthcare company whose mission […]
- GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 . . .
GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages
- GRAIL Reports Third Quarter 2025 Financial Results
GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages
- Careers - GRAIL
To pursue a mission like GRAIL’s, it takes a unified collective of courageous, adaptable, and open-minded big thinkers dedicated to creating a better world Because we’ve set our sights high, the work we’re doing asks a lot of us Pursuing scientific breakthroughs, scaling for growth, and driving change across a dynamic operating environment requires next-level creativity and
- GRAIL Announces Integration of the Galleri® Test into Epic Electronic . . .
GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages
- Multi-cancer early detection - GRAIL
Multi-cancer early detection (MCED) testing is a new approach to screening for cancer Adding a blood-based multi-cancer early detection test can help screen for many of the deadliest cancers that don’t have recommended screening today 7,8
|
|
|